🟢 Neurosense Therapeutics is trading 7.2% up today on broader market strength

Neurosense Therapeutics is trading 7.2% up at $6.81, supported by stronger broader markets.

• The move follows a 5.51% decline to $6.35 on September 18.
• Coverage attributes the premarket advance to broader markets: S&P 500 up 0.65% and Nasdaq Composite up 1.10%. Declining oil prices, easing bond yields, and improving risk appetite support growth and technology shares.
• No fresh company-specific announcement dated September 21 was identified; the move appears global rather than company-specific, with no confirmed clinical, regulatory, financing, or earnings catalyst.